Genus Stock Price, News & Analysis (OTCMKTS:GENSF) $28.35 0.00 (0.00%) (As of 11/30/2023 ET) Add Compare Share Share Today's Range$28.35▼$28.3550-Day Range$26.79▼$28.3552-Week Range$26.79▼$28.35VolumeN/AAverage Volume650 shsMarket CapitalizationN/AP/E Ratio59.55Dividend Yield0.59%Price TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort Interest About Genus Stock (OTCMKTS:GENSF)Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers technical services to farmers. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.Read More GENSF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GENSF Stock News HeadlinesAugust 4, 2023 | ca.finance.yahoo.comGenus plc (GENSF)June 6, 2023 | finance.yahoo.comWith 88% ownership of the shares, Genus plc (LON:GNS) is heavily dominated by institutional ownersDecember 1, 2023 | Tomorrow Investor (Ad)The Only Practical Solution to the World’s Looming Energy CrisisThere’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!May 16, 2023 | marketwatch.comGenus Expects 2023 Pretax Profit to Fall on Challenges in China's Pig SectorMay 16, 2023 | lse.co.ukGenus expects China business to swing to loss on weak porcine marketsApril 14, 2023 | cbsnews.comFamily members Vern Moore, Velma Genus “You’re my hero in every meaning of the word”April 4, 2023 | marketwatch.comGenus Names Jorgen Kokke as Chief Executive Officer DesignateFebruary 23, 2023 | marketwatch.comGenus Shares Rise After 2023 View Backed, Posted Higher 1H Revenue, VolumesDecember 1, 2023 | Tomorrow Investor (Ad)The Only Practical Solution to the World’s Looming Energy CrisisThere’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!November 23, 2022 | marketwatch.comGenus Backs FY 2023 View Following Good Start to YearOctober 7, 2022 | benzinga.comGenus Stock (OTC:GENSF), Analyst Ratings, Price Targets, PredictionsSeptember 16, 2022 | investing.comGenus Power Infrastructures Ltd (GEOE)September 8, 2022 | thetimes.co.ukGenus given lift by China’s pork marketSeptember 8, 2022 | marketwatch.comGenus FY 2022 Pretax Profit Fell on Lower Performance of a Biological AssetSeptember 4, 2022 | nz.finance.yahoo.comGenus (LON:GNS) sheds UK£52m, company earnings and investor returns have been trending downwards for past yearJuly 21, 2022 | finance.yahoo.comForm 8.3 - Genus Plc - CORRECTIONJune 10, 2022 | uk.finance.yahoo.comWhat do city experts think about the outlook for Genus?May 21, 2022 | uk.finance.yahoo.comWhich way now for the Genus share price?May 4, 2022 | finance.yahoo.comIs The Market Rewarding Genus plc (LON:GNS) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?April 2, 2022 | nypost.comNo bulls–t: Genus Plc to breed eco-friendly, low-farting cowsFebruary 14, 2022 | finance.yahoo.comGenus plc's (LON:GNS) Intrinsic Value Is Potentially 18% Below Its Share PriceFebruary 8, 2022 | nasdaq.comGENSF After-Hours QuotesNovember 24, 2021 | lse.co.ukGenus shares slump 13% due to Chinese pig market challengesNovember 24, 2021 | marketwatch.comGenus Expects Lower FY 2022 Pretax Profit on China WoesNovember 24, 2021 | nasdaq.comGenus Says Meets Profit Expectations Except In PIC ChinaNovember 24, 2021 | thetimes.co.ukChinese pig market challenges hit GenusOctober 18, 2021 | finance.yahoo.comInvesting in Genus (LON:GNS) five years ago would have delivered you a 189% gainSee More Headlines Receive GENSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genus and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:GENSF CUSIPN/A CIKN/A Webwww.genusplc.com Phone441256347100FaxN/AEmployees3,500Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio59.55 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Jorgen Kokke (Age 55)Chief Executive Officer & Director Comp: $731kMs. Alison Jane Henriksen ACA (Age 56)CFO & Executive Director Comp: $762.3kDr. Matt CulbertsonChief Operating OfficerDr. Elena RiceHead of R&D and Chief Scientific OfficerMr. Daniel William David HartleyGroup General Counsel & Company SecretaryMs. Angelle R. RosataGroup Human Resources DirectorMr. Jerry ThompsonChief Operating Officer of Genus ABS BeefDr. Nate ZwaldChief Operating Officer of Genus ABS DairyAndrew ThompsonHead of ABS EMEAMs. Janet DuaneGroup Financial ControllerMore ExecutivesKey Competitors3SBioOTCMKTS:TRSBF60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFAdociaOTCMKTS:ADOIFAgentixOTCMKTS:AGTXView All Competitors GENSF Stock Analysis - Frequently Asked Questions Should I buy or sell Genus stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Genus in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" GENSF shares. View GENSF analyst ratings or view top-rated stocks. How have GENSF shares performed in 2023? Genus' stock was trading at $34.40 on January 1st, 2023. Since then, GENSF shares have decreased by 17.6% and is now trading at $28.3450. View the best growth stocks for 2023 here. Are investors shorting Genus? Genus saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 400 shares, an increase of 33.3% from the October 31st total of 300 shares. Based on an average trading volume of 200 shares, the days-to-cover ratio is presently 2.0 days. View Genus' Short Interest. Is Genus a good dividend stock? Genus (OTCMKTS:GENSF) pays an annual dividend of $0.17 per share and currently has a dividend yield of 1.48%. The dividend payout ratio is 34.87%. This payout ratio is at a healthy, sustainable level, below 75%. How do I buy shares of Genus? Shares of GENSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (OTCMKTS:GENSF) was last updated on 12/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genus plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.